HomeMarket NewsCharles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying

Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying

Actionable Trade Ideas

always free






Insider Trading Buzz in Penny Stocks

Dow Jones Sees Slight Gain as Insider Trading Raises Eyebrows

image20

The Dow Jones index closed higher by around 0.1% on Wednesday. Do insiders know something we don’t? When insiders buy or sell shares, it signals their confidence – or lack thereof – in the company’s future. For those keen on penny stocks, insider trading can offer a glimpse into the company’s potential. A piece of the puzzle worth considering.

What are the hot scoops? Here’s a look at some recent and noteworthy insider trades in the world of penny stocks. Seek more insights on Benzinga’s platform for insider transactions.

The Stealthy Move: Rezolute

  • The Trade: In a bold maneuver, Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc. RZLT scooped up 7,000 shares at an average price of $1.31, amounting to approximately $9,142.
  • Company Buzz: Rezolute announced a narrower-than-anticipated quarterly loss, setting tongues wagging in the market.
  • What’s Cooking: Rezolute Inc is a biopharmaceutical company cooking up novel, sustained-release injectable therapies.

Cosmos Health’s Strategic Play

  • The Move: With a tactical move, Grigorios Siokas, CEO of Cosmos Health Inc. COSM acquired 60,000 shares at an average price of $0.83, amounting to a handsome $49,806.
  • Latest Buzz: Cosmos Health successfully wrapped up the acquisition of Cloudscreen®, an avant-garde Artificial Intelligence (AI) powered platform.
  • What’s Cosmos Health About: Cosmos Health Inc dives into the nutraceuticals realm with its exclusive product lines ‘Sky Premium Life’ and ‘Mediterranation’.

Curious about more top picks? Don’t miss out on our premarket coverage.

InMed Pharmaceuticals Makes a Statement

  • The Power Move: Stepping up, Eric A Adams, President and CEO of InMed Pharmaceuticals Inc. INM secured 41,600 shares at an average price of $0.36, shelling out a cool $14,922.
  • Recent Buzz: InMed Pharmaceuticals revealed the selection of a lead Alzheimer’s drug candidate following promising proof-of-concept study data in October.
  • What’s Their Flavor: InMed Pharmaceuticals Inc, hailing from the land of Canada, is a clinical-stage biopharmaceutical enterprise.

Charles & Colvard: Gem of a Move?

  • The Sparkling Move: Ollin B Sykes, the Director of Charles & Colvard, Ltd. CTHR nabbed 125,000 shares at an
    average price of $0.37, lighting a fire to the tune of $46,737.
  • What’s Up: Charles & Colvard reported a loss of 9 cents per share in the last quarter. Shine or a mere glimmer?
  • What’s Their Sparkle: Charles & Colvard Ltd showcases its prowess in churning out finished jewelry, including the mesmerizing moissanite gemstone, into the jewelry industry.

Keen for more market insights? Dive into NVIDIA, Keurig Dr Pepper, and 3 other stocks heading into Thursday.


Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.